Sassicaia Capital Advisers LLC Sio Gene Therapies Inc. Call Options Transaction History

Sassicaia Capital Advisers LLC

  • $24.7 Billion
  • Q2 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding SIOX

# of Institutions
2
Shares Held
147K
Call Options Held
0
Put Options Held
0
View Full List

About Sio Gene Therapies Inc.

SIOX Quotes by TradingView
  • Ticker SIOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,975,200
  • Description
  • Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...
More about SIOX
Track This Portfolio

Track Sassicaia Capital Advisers LLC Portfolio

Follow Sassicaia Capital Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sassicaia Capital Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sassicaia Capital Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email